BAYER AG NA O.N. (BAYN.DE) Financials
BAYN.DE Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-12-31 | 123.3 billion | 90.3 billion |
2023-09-30 | 117.2 billion | 83.7 billion |
2023-06-30 | 121.7 billion | 84.5 billion |
2023-03-31 | 125.1 billion | 84.0 billion |
BAYN.DE Free Cash Flow and Stock based compensation
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-12-31 | 4.3 billion | 195.0 million |
2023-09-30 | 1.9 billion | ? |
2023-06-30 | -122.0 million | ? |
2023-03-31 | -4.0 billion | ? |
BAYN.DE Net Income
Date | Net Income |
---|---|
2023-12-31 | 1.3 billion |
2023-09-30 | -4.6 billion |
2023-06-30 | -1.9 billion |
2023-03-31 | 2.2 billion |
BAYN.DE Cash and Debt
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-12-31 | 10.6 billion | - | 1.2 billion |
2023-09-30 | 9.3 billion | 35.1 billion | - |
2023-06-30 | 7.6 billion | 36.6 billion | - |
2023-03-31 | 8.0 billion | 33.6 billion | - |
BAYN.DE Shares Outstanding
BAYN.DE Expenses
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-12-31 | 996.0 million | 1.1 billion | 755.0 million | 2.8 billion |
2023-09-30 | 683.0 million | 1.5 billion | 551.0 million | 3.1 billion |
2023-06-30 | 606.0 million | 1.2 billion | 489.0 million | 3.2 billion |
2023-03-31 | 466.0 million | 1.6 billion | 658.0 million | 3.4 billion |
BAYN.DE Cost of Revenue
Date | Revenue | Cost of Revenue |
---|---|---|
2023-12-31 | 11.9 billion | 4.5 billion |
2023-09-30 | 10.3 billion | 4.8 billion |
2023-06-30 | 11.0 billion | 4.7 billion |
2023-03-31 | 14.4 billion | 5.7 billion |
BAYN.DE
Price: €27.35
Dividend Yield: 0.00%
Forward Dividend Yield: 0.40%
Payout Ratio: -64.17%
Dividend Per Share: 0.11 EUR
Earnings Per Share: -2.99 EUR
P/E Ratio: -7.51
Exchange: GER
Sector: Healthcare
Industry: Drug Manufacturers - General
Volume: 2.0 million
Market Capitalization: 26.0 billion
Average Dividend Frequency: 1
Years Paying Dividends: 24
DGR3: -3.36%
DGR5: -1.70%
DGR10: 3.44%
DGR20: 7.45%